CompletedNCT03966105

Prevalence of Wild Type ATTR

Studying Amyloidosis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Oncology Institute of Southern Switzerland
Principal Investigator
Adalgisa Condoluci, MD
Oncology Institute of Southern Switzerland
Intervention
HE and Congo red staining(diagnostic_test)
Enrollment
94 enrolled
Eligibility
50 years · All sexes
Timeline
2019 – 2022

Study locations (1)

Collaborators

University of Kiel · Ente Ospedaliero Cantonale, Bellinzona

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03966105 on ClinicalTrials.gov

Other trials for Amyloidosis

Additional recruiting or active studies for the same condition.

See all trials for Amyloidosis →

← Back to all trials